| scholarly article | Q13442814 |
| P50 | author | Jennifer Clare Jones | Q55471994 |
| P2093 | author name string | Zhenyu Yao | |
| Samuel Strober | |||
| Yinping Liu | |||
| P2860 | cites work | Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death | Q24312211 |
| Bcl-XL and Bcl-2 repress a common pathway of cell death | Q28505812 | ||
| Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair | Q28586758 | ||
| CD1 recognition by mouse NK1+ T lymphocytes | Q28591238 | ||
| p53 is required for radiation-induced apoptosis in mouse thymocytes | Q29620281 | ||
| Recognition and function of Valpha14 NKT cells | Q34123059 | ||
| Anti-apoptotic Bcl-2 proteins: structure, function and relevance for radiation biology | Q34795688 | ||
| NKT cells are relatively resistant to apoptosis | Q35751884 | ||
| The diverse functions of CD1d-restricted NKT cells and their potential for immunotherapy | Q36220141 | ||
| Transplantation of allogeneic bone marrow without graft-versus-host disease using total lymphoid irradiation | Q36340172 | ||
| V alpha14 i NKT cells are innate lymphocytes that participate in the immune response to diverse microbes | Q36354705 | ||
| Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen | Q36355970 | ||
| Bad can act as a key regulator of T cell apoptosis and T cell development. | Q36367710 | ||
| A nonclassical non-Valpha14Jalpha18 CD1d-restricted (type II) NKT cell is sufficient for down-regulation of tumor immunosurveillance | Q36403071 | ||
| Identification of an early T cell progenitor for a pathway of T cell maturation in the bone marrow | Q36746464 | ||
| NKT cells: T lymphocytes with innate effector functions | Q36788766 | ||
| Allograft Tolerance after Total Lymphoid Irradiation (TLI) | Q39269419 | ||
| Tolerance and chimerism after renal and hematopoietic-cell transplantation | Q40428891 | ||
| Host-residual invariant NK T cells attenuate graft-versus-host immunity | Q43515226 | ||
| bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes | Q44192187 | ||
| Effect of KRN7000 on induced graft-vs-host disease | Q44956752 | ||
| Recipient CD4+ T cells that survive irradiation regulate chronic graft-versus-host disease | Q47586153 | ||
| IL-4-producing NK1.1+ T cells are resistant to glucocorticoid-induced apoptosis: implications for the Th1/Th2 balance | Q47757246 | ||
| NKT cells: what's in a name? | Q47895830 | ||
| Systemic overexpression of BCL-2 in the hematopoietic system protects transgenic mice from the consequences of lethal irradiation. | Q52188936 | ||
| Host NKT cells can prevent graft-versus-host disease and permit graft antitumor activity after bone marrow transplantation. | Q53555765 | ||
| Down-regulation of the invariant Valpha14 antigen receptor in NKT cells upon activation. | Q53905529 | ||
| Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance | Q59074162 | ||
| Stimulation of Host NKT Cells by Synthetic Glycolipid Regulates Acute Graft-versus-Host Disease by Inducing Th2 Polarization of Donor T Cells | Q63363303 | ||
| Host conditioning with total lymphoid irradiation and antithymocyte globulin prevents graft-versus-host disease: the role of CD1-reactive natural killer T cells | Q73544447 | ||
| Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors | Q73889862 | ||
| Predominance of NK1.1+TCR alpha beta+ or DX5+TCR alpha beta+ T cells in mice conditioned with fractionated lymphoid irradiation protects against graft-versus-host disease: "natural suppressor" cells | Q74321466 | ||
| Immune tolerance to combined organ and bone marrow transplants after fractionated lymphoid irradiation involves regulatory NK T cells and clonal deletion | Q78488955 | ||
| Augmentation of innate immunity by low-dose irradiation | Q80124803 | ||
| Protective conditioning for acute graft-versus-host disease | Q81279975 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 763-775 | |
| P577 | publication date | 2009-03-01 | |
| P1433 | published in | European Journal of Immunology | Q5412727 |
| P1476 | title | Differences in Bcl-2 expression by T-cell subsets alter their balance after in vivo irradiation to favor CD4+Bcl-2hi NKT cells | |
| P478 | volume | 39 |
| Q37729199 | 2-Gy whole-body irradiation significantly alters the balance of CD4+CD25−T effector cells and CD4+CD25+Foxp3+T regulatory cells in mice |
| Q47820461 | CD1d-Restricted pathways in hepatocytes control local natural killer T cell homeostasis and hepatic inflammation |
| Q88321753 | Enhanced Lymphodepletion Is Insufficient to Replace Exogenous IL2 or IL15 Therapy in Augmenting the Efficacy of Adoptively Transferred Effector CD8+ T Cells |
| Q37768104 | NKT cells, Treg, and their interactions in bone marrow transplantation |
| Q37610711 | Nonmyeloablative conditioning with total lymphoid irradiation and antithymocyte globulin: an update |
| Q42793688 | Recipient myeloid-derived immunomodulatory cells induce PD-1 ligand-dependent donor CD4+Foxp3+ regulatory T cell proliferation and donor-recipient immune tolerance after murine nonmyeloablative bone marrow transplantation |
| Q36462109 | Regulatory T Cell Immunotherapy in Immune-Mediated Diseases |
| Q38625892 | Selective resistance of CD44hi T cells to p53-dependent cell death results in persistence of immunologic memory after total body irradiation |
| Q37291642 | TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donors |
| Q33914718 | The changed balance of regulatory and naive T cells promotes tolerance after TLI and anti-T-cell antibody conditioning |
| Q35662003 | Third-party CD4+ invariant natural killer T cells protect from murine GVHD lethality |
| Q52801888 | Tolerogenic interactions between CD8+ dendritic cells and NKT cells prevent rejection of bone marrow and organ grafts. |
| Q37894465 | Translational studies in hematopoietic cell transplantation: treatment of hematologic malignancies as a stepping stone to tolerance induction |
| Q36727857 | Use of hematopoietic cell transplants to achieve tolerance in patients with solid organ transplants |
Search more.